Intellia Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 42 U.S.-traded ETFs. NTLA has around 10.7M shares in the U.S. ETF market. The largest ETF holder of NTLA is the ARK Innovation ETF (ARKK), with approximately 4.86M shares. Investors may also find of interest that the ETF with the largest allocation to NTLA stock is ARK Genomic Revolution ETF (ARKG), with a portfolio weight of 5.96%. On average, U.S. ETFs allocate 0.32% of NTLA to their portfolios.
Additionally, NTLA is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with NTLA as a holding is the Fidelity NASDAQ Composite Index Tracking Stock (ONEQ), with a return of 15.93%.